B-205826:
Mar 16, 1982
A firm protested the anticipated rejection of its bid to supply hydrocortisone by the Defense Logistics Agency (DLA) on the basis that it was not a responsible bidder. A preaward quality survey performed by the Food and Drug Administration (FDA) at the request of DLA revealed that the protester's product required a new drug application (NDA) or an abbreviated new drug application (ANDA) as a prere...